POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

FDA panel rejects call for third Pfizer booster shot

Christian Fernsby |
A Food and Drug Administration (FDA) advisory panel voted on Friday against an additional, third booster shot of the COVID-19 vaccine from Pfizer-BioNTech.

Article continues below




Both the Pfizer and Moderna drug companies have said a third booster shot is inevitable, but the question for the advisory panel was whether a booster shot for average Americans was needed now, about 10 months after they started rolling out.

Pfizer has argued that its data shows a booster shot is needed after six months of the initial dose; Moderna has argued that boosters for its vaccine should come after eight months and the White House had also been targeting an eighth month booster shot.

But the FDA panel ruled solely on the Pfizer-BioNTech booster shot, and rejected it. The panel considered data from Israel, showing that vaccine efficacy declines after six months. But there are differences in the way the US and Israel calculate COVID-19 illnesses, and the Israeli data also showed that the vaccine's protection against serious illness remains strong after six months.

Also up for debate has been the belief that more initial vaccine doses need to be distributed world-wide before the average, fully-vaccinated American gets a third, booster shot.

Still, a third booster shot will be rolling out across the US, starting on Monday, for people who are considered at higher-risk of catching COVID-19, and have compromised immune systems. The Centers for Disease Control and Prevention (CDC) will announce on Monday more guidance on where those doses will go.

Separately, the CDC announced that its finding show that Moderna's vaccine offers a better protection against hospitalization than the other widely-used vaccines. The CDC says the Moderna vaccine offers a protection rate of 93%, compared to a rate of 88% for the Pfizer-BioNTech vaccine, and 71% for the Johnson & Johnson vaccine.


What to read next

Japan considers to begin administering 3rd shots of COVID-19 vaccine by year-end
Consumers remain highly skeptical of the vaccine
Pfizer and BioNTech believe thirds dose will be beneficial against Indian Delta COVID-19 variant